StockTipsArenaBeta

BUY Sun Pharmaceutical Industries Ltd. — Shrikant Chouhan, Kotak Securities

BUYSun Pharmaceutical Industries Ltd.
Sun Pharmaceutical Industries share price target & all analyst calls

byShrikant Chouhan, Kotak SecuritiesHorizon: NA (inferred Swing (≤2wk))9 Jul 2026via CNBC Awaaz.

Entry₹1,923.9Inferred
Target₹2,200
Total upside +14.35% (call closed)
Stop lossNot given
At expiry₹1,943.922 Jul 2026, 3:30 pm
Expired+1.04%
Follow Shrikant Chouhan for new calls(26% target hit, 107 closed calls)Get alertsWatch SUNPHARMA for new buy/sell callsGet alertsSee 149 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 22 Jul 2026
2 supporting0 opposing
Supports the BUY call (2)

3 other SEBI-registered advisors have active swing BUY calls on this stock, all issued in the last 14 days

Advisor consensus · same horizon·15 Jul · 6d ago

Sun Pharmaceutical Industries Limited has received approval to manufacture and market a generic version of semaglutide in South Africa, expanding its product portfolio and market access.

NSE · Press Release·15 Jul · 1w ago

(opens in new tab)
Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Sun Pharmaceutical Industries

All analyst calls on Sun Pharmaceutical Industries

More from Shrikant Chouhan, Kotak Securities

Every call and its outcome